Cardiac Resynchronization Therapy - Current Status and Future Perspectives;Kardiale Resynchronisationstherapie - Aktueller Stand und zukünftige Perspektiven

Herz

Volumn 28, Issue 7, 2003, Pages 607-614

  Stellbrink, Christoph ^a   Breithardt, Ole Alexander ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

Cardiac resynchronization therapy; Heart failure; Pacemaker

Indexed keywords

ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EXERCISE; FUTUROLOGY; GENERAL CONDITION IMPROVEMENT; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HEART RESYNCHRONIZATION THERAPY; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; IMPLANTATION; LONG TERM CARE; MITRAL VALVE REGURGITATION; MORTALITY; PRACTICE GUIDELINE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CLINICAL TRIALS; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HOSPITALIZATION; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; PRACTICE GUIDELINES; RADIOGRAPHY, THORACIC; RANDOMIZED CONTROLLED TRIALS; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0344394219     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-003-2502-z     Document Type: Review

References (55)

1. De Maria R, Gavazzi A, Recalcati F, Baroldi G, De Vita C, Camerini F. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC). Am J Cardiol 1993;72:580-5.
2. Moss AJ, Zareba W, Hall J, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
3. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M, Campana C, Perini G, Deorsola A, Masotti G, Tavazzi L, Maggioni AP. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002;143:398-405.
4. Hochleitner M, Hortnagl H, Ng C, Hortnagl H, Gschnitzer F, Zechmann W. Usefulness of physiologic dual-chamber pacing in drug resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990;66:198-202.
5. Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995;26:967-73.
6. Prinzen FW, Peschar M. Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol 2002;25:484-98.
7. Blanc JJ, Etienne Y, Gilard M, Mansourati J, Munier S, Boschat J, Benditt DG, Lurie KG. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997;96:3273-7.
8. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H for the PATH-CHF Study Group and Kramer A, Ding J, Salo R, Tockman B, Pochet T, Spinelli J for the Guidant CHF Research Group. The effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999;99:2993-3001.
9. Kass DA, Chen CH, Curry C, Talbot M, Berger R, Fetics B, Nevo E. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567-73.
10. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000;102:3053-9.
11. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, Stellbrink C. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765-70.
12. Daubert JC, Ritter P, Le Breton H, Gras D, Leclercq C, Lazarus A, Mugica J, Mabo P, Cazeau S. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 1998;21:239-45.
13. Bakker PF, Meijburg HW, de Vries JW, Mower MM, Thomas AC, Hull ML, Robles De Medina EO, Bredee JJ. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J Interv Card Electrophysiol 2000;4:395-404.
14. Gras D, Mabo P, Tang T, Luttikuis O, Chatoor R, Pedersen AK, Tscheliessnigg KH, Deharo JC, Puglisi A, Silvestre J, Kimber S, Ross H, Ravazzi A, Paul V, Skehan D. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync study. Pacing Clin Electrophysiol 1998;21:2249-55.
15. Cazeau S, Leclercq C, Lavergne T, et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
16. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schöndube FA, Wolfhard U, Böcker D, Krahnefeld O, Kirkels H. Chronic effect of hemodynamically optimized cardiac resynchronization therapy on patients with heart failure and ventricular conduction delay, J Am Coll Cardiol 2002;39:2026-33.
17. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Messenger J, for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
18. Stellbrink C, Breithardt OA, Franke A, Sack S, Bakker P, Auricchio A, on behalf of the PATH-CHF Investigators and Thierry Pochet, Rod Salo, Andrew Kramer and Julio Spinelli on behalf of the CPI Guidant CHF Research Group. Impact of cardiac resynchronisation therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbance. J Am Coll Cardiol 2001;38:1957-65.
19. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002;105:1304-10.
20. Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, Lin H, Kong SL, Lam YM, Hill MR, Lau CP. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002;105:438-45.
21. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MR; Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-90.
22. Fauchier L, Marie O, Casset-Senon D, Babuty D, Cosnay P, Fauchier JP. Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with fourier phase analysis of radionuclide angioscintigraphy. J Am Coll Cardiol. 2002;40:2022-30.
23. Stellbrink C, Nowak B. The Importance of being synchronous - on the prognostic value of ventricular conduction delay in heart failure. J Am Coll Cardiol 2002;40:2031-3.
24. Butter C, Auricchio A, Stellbrink C, Sack S, Vogt J, Ramdat Misier A, Boecker D, Block M, Kirkels H, Huvelle E, Kramer A, Pochet T. Cardiac resynchronisation therapy stratified by QRS duration: Path-CHF II results at one year. Pacing Clin Electrophysiol 2003;26:220.abstract.
25. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC Jr; American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61.
26. Auricchio A, Spinelli JC. The promise of resynchronization therapy. Who (and how many) will benefit? Card Electrophysiol Rev 2003;7:17-26.
27. Leclercq C, Cazeau S, Ritter P, Alonso C, Gras D, Mabo P, Lazarus A, Daubert JC. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000;140:862-70.
28. Kühlkamp V, and InSync 7272 ICD World Wide Investigators. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002;39:790-7.
29. Garrigue S, Reuter S, Labeque JN, Jais P, Hocini M, Shah DC, Haissaguerre M, Clementy J. Usefulness of biventricular pacing in patients with congestive heart failure and right bundle branch block. Am J Cardiol 2001;88:1436-41.
30. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology and rationale for therapy. Am J Cardiol 2003;91:Suppl:2D-8D.
31. Twidale N, Manda V, Nave K, Seal A. Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure. Am Heart J 1998;136:647-57.
32. Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, Lloyd MA, Packer DL, Hodge DO, Hayes DL, Gersh BJ, Hammill SC, Shen WK. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001;344:1043-51.
33. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, Langberg JJ, DeLurgio DB. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258-63.
34. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, Djiane P, Mabo P, Levy T, Gadler F, Bailleul C, Daubert JC. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-7.
35. Stellbrink C, Auricchio A, Lemke B, von Scheidt W, Vogt J, Dietz R, Gottwik M, Levenson B, Meinertz T, Osterspey A, Tebbe U, Strasser RH, Werdan K, Arnold G, Behrenbeck D, Fleck E, Trappe HJ. Positionspapier zur kardialen Resynchronisationstherapie. Z Kardiol 2003;92:96-103.
36. Leclercq C, Cazeau S, Ritter P, Alonso C, Gras D, Mabo P, Lazarus A, Daubert JC. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000;140:862-70.
37. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, Powe NR. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. J Am Med Assoc 2003;289:730-40.
38. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Klein W, Tavazzi L. The CARE-HF study (CArdiac RE-synchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail 2001;3:481-9.
39. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail 2000;6:276-85.
40. Bristow MR, Saxon LA, Boehmer J, et al. for the COMPANION Investigators. Cardiac resynchronization therapy (CRT) reduces hospitalizations, and CRT + an implantable defibrillator (CRT-D) reduces mortality in chronic heart failure: preliminary results of the COMPANION trial. Presented at the Annual Meeting of the ACC 2003.
41. Touiza A, Etienne Y, Gilard M, Fatemi M, Mansourati J, Blanc JJ. Long-term left ventricular pacing: assessment and comparison with biventricular pacing in patients with severe congestive heart failure. J Am Coll Cardiol. 2001;38:1966-70.
42. Auricchio A, Ding J, Yu Y, Pochet T, Kramer A, Salo R, Spinelli J. Comparison between the effect of pacing on the RV and LV systolic function of heart failure patients. PACE Pacing Clin Electrophysiol 1999;22:831.abstract.
43. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
44. The MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
45. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
46. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease. The Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
47. Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002;105:1453-8.
48. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F and the AMIOVIRT Investigators. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol 2003;41:1707-12.
49. Pappone C, Rosanio S, Burkhoff D, Mika Y, Vicedomini G, Augello G, Shemer I, Prutchi D, Haddad W, Aviv R, Snir Y, Kronzon I, Alfieri O, Ben-Haim SA. Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2002;90:1307-13.
50. Erlebacher JA, Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am J Cardiol 2001;88:83-6.
51. Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J 1991;66:443-7.
52. Breithardt OA, Stellbrink C, Kramer A, Salo R, Sinha AM, Schiffgens B, Huvelle E, Auricchio A, for the Pacing Therapies for Congestive Heart Failure Study Group. Echocardiographic quantification of left ventricular asynchrony predicts acute benefit of cardiac resynchronization therapy in patients with heart failure and conduction delay. J Am Coll Cardiol 2002;40:536-45.
53. Sogaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BO, Mortensen PT. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term resynchronization therapy. J Am Coll Cardiol 2002;40:723-30.
54. Yu CM, Fung WH, Lin H, Zhang O, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003;91:684-8.
55. Pitzalis MV, Iacoviello M, Romito R, Massari F, Rizzon B, Luzzi G, Guida P, Andriani A, Mastropasqua F, Rizzon P. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-22.